Phase II Trial of EMD 121974 [Cilengitide] for Recurrent Glioblastoma : A Clinical Trial With Tissue Correlates of Response.
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Cilengitide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 16 May 2017 Status changed from completed to discontinued.
- 19 Dec 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Oct 2007 Status changed from recruiting to in progress.